Hana Pharm Co Ltd Total Liabilities

Latest as of June 2026: ₩114.94 Billion KRW ≈ $77.89 Million USD

Hana Pharm Co Ltd total liabilities. Based on the latest financial reports, Hana Pharm Co Ltd (293480) has total liabilities worth ₩114.94 Billion KRW (≈ $77.89 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Hana Pharm Co Ltd (293480) asset resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Hana Pharm Co Ltd (2016–2025)

Total liabilities of Hana Pharm Co Ltd from 2016 to 2025. This chart illustrates how Hana Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Hana Pharm Co Ltd (293480) investment intensity to see how much of total assets are deployed in long-term investments.

Hana Pharm Co Ltd Competitors by Total Liabilities

The table below lists competitors of Hana Pharm Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Logistic Properties of the Americas NYSE MKT:LPA	USA	$376.20 Million
Kewaunee Scientific Corporation NASDAQ:KEQU	USA	$98.58 Million
Samick Thk KO:004380	Korea	₩257.11 Billion
Amotech Co. Ltd KQ:052710	Korea	₩175.85 Billion
Humacyte Inc NASDAQ:HUMA	USA	$113.26 Million
Yoosung T&S Co. Ltd KQ:024800	Korea	₩99.40 Billion
Taeyang Metal Industrial Co Ltd KO:004105	Korea	₩443.01 Billion
Accel Solutions Group Ltd TA:ACCL	Israel	ILA292.30 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Hana Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 293480 current and non-current assets.

Liquidity & Leverage Metrics

Hana Pharm Co Ltd Total Liabilities Ratios Explained

Hana Pharm Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.96	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hana Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hana Pharm Co Ltd (2016–2025)

The table below shows the annual total liabilities of Hana Pharm Co Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩104.73 Billion ≈ $70.98 Million	+43.79%
2024-12-31	₩72.83 Billion ≈ $49.36 Million	+3.46%
2023-12-31	₩70.40 Billion ≈ $47.71 Million	-9.24%
2022-12-31	₩77.57 Billion ≈ $52.57 Million	+50.34%
2021-12-31	₩51.60 Billion ≈ $34.97 Million	+16.74%
2020-12-31	₩44.20 Billion ≈ $29.95 Million	+3.50%
2019-12-31	₩42.70 Billion ≈ $28.94 Million	+15.43%
2018-12-31	₩36.99 Billion ≈ $25.07 Million	-38.60%
2017-12-31	₩60.25 Billion ≈ $40.83 Million	+1.94%
2016-12-31	₩59.11 Billion ≈ $40.06 Million	--

About Hana Pharm Co Ltd

KO:293480 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$97.89 Million

₩144.44 Billion KRW

Market Cap Rank

#19080 Global

#918 in Korea

Share Price

₩8150.00

Change (1 day)

-0.49%

52-Week Range

₩8070.00 - ₩11820.00

All Time High

₩26028.86